“As on January 30, 2022, a total of 70,102 cases (Covishield – 63,315, Covaxin – 6,757 and Sputnik – 30) of Adverse Events Following Immunization (AEFIs) and 1,013 cases of death (Covishield – 921, Covaxin – 92, and Sputnik ‘Nil‘) have been reported,” junior well being minister Bharti Pawar stated.
In a written reply, Pawar stated the operational tips for Covid-19 vaccination present steering on classification, prevention, reporting and administration of the features of AEFI.
Frequent communication to the states and UTs by letters, advisories (like inclusion of obstetricians or gynecologists within the state or district AEFI committees) have been issued to enhance the reporting of minor, extreme and severe circumstances of AEFI.
The variety of AEFI circumstances reported in developed nations is extra as self-reporting of adversarial drug reactions and utilizing web for reporting AEFI on-line is properly established in these nations, she added.
AEFI is monitored by a well-structured and sturdy surveillance system in India, the minister stated.
Causality evaluation of all severe and extreme AEFI circumstances is finished by the designated AEFI committee to find out whether it is associated to the vaccine or vaccination course of.
The AEFI Committee displays vaccine security and recommends motion to enhance AEFI surveillance. There isn’t any suggestion to make reporting of AEFI circumstances obligatory for the healthcare service suppliers, Pawar stated.
Periodic letters and month-to-month state-specific displays on efficiency of AEFI surveillance with motion factors can be shared with the states, which have been requested to commonly sensitize the healthcare service suppliers, together with the non-public healthcare service suppliers, to report AEFI following vaccination, she stated.